RE:RE:Q3 ResultsGreat quarter which presages increasingly stronger quarters ahead.
The Medline deal kicks in this quarter and the $11 million + SA deal kicks in beginning in Q4.
Plus the 9 countries already signed in Latin America and 8 more to be signed within months.
And new products being added to the pipeline.
And of course the new China office will soon announce their first deals .
The current run rate of $10.5 million /year should easily move to the $40 million range by this time next year, with large markets like the EU awaiting penetration.
Its not too difficult to see how management have scoped out a market cap of $1 billion within 4 years.